Abstract
Background Non-adherence to prescribed medication regimens can lead to suboptimal control of chronic health conditions and increased hospitalizations. Older adults may find it particularly challenging to self-manage medications due to physical and cognitive limitations resulting in medication non-adherence. While automated medication dispensing technologies may offer a solution for medication self-management among older adults, these technologies must demonstrate usability before effectiveness can be investigated and products made available for widespread use.
Objectives This study will aim to measure usability, workload, and unassisted task completion rates of an automated medication dispenser and medication adherence dashboard on the Medipense portal with older adults and their clinicians, respectively.
Methods This study is designed as convergent parallel mixed methods observational study with older adults and their clinicians. Usability will be examined with the use the System Usability Scale while NASA-TLX will be utilized to assess the workload of both the device and the adherence monitoring platform. Cognitive walkthrough will be utilized prior to usability testing to identify series of steps required to use the automated dispenser and adherence dashboard. The study will assess the unassisted task completion rates to successfully operate the device. Semi-structured interviews with both types of participants will provide qualitative data with which to comprehensively gauge user experience with the automated dispenser.
Results The results of this study will allow us to examine usability of both the automated medication dispensing system and the adherence monitoring dashboard from older adult and heath care provider perspectives. The results of this study will highlight and address the challenges with usability that older adults and healthcare providers may face with this device and dashboard.
Conclusions: The results of this study will be used to optimize the usability of both the automated medication dispenser and the adherence dashboard.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
- The Hôpital Montfort Research Ethics Board (HM-REB)File number: 19-20-08-020 - In accordance with the latest edition of Tri-Council Policy Statement - Ethical Conduct for Research Involving Humans Subjects (TCPS 2), I confirm that the Hôpital Montfort Research Ethics Board (REB) has evaluated and approved the research project
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Deidentified research data will be made publicly available when the study is completed and published.
